Jacobs Levy Equity Management’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-310,514
Closed -$475K 965
2026
Q1
$475K Buy
+310,514
New +$408K ﹤0.01% 838
2025
Q1
Sell
-197,528
Closed -$766K 1081
2024
Q4
$766K Buy
+197,528
New +$1.57M ﹤0.01% 752

Other funds holding BMEA

Jacobs Levy Equity Management's BMEA Position: Q2 2026 in Review

Jacobs Levy Equity Management sold out of Biomea Fusion (BMEA) in Q2 2026, closing a stake of 310,514 shares — an estimated $475K sold.

Jacobs Levy Equity Management first reported a position in BMEA in Q4 2024 and held it in 2 quarters. The position peaked at $766K in Q4 2024. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.

  • Jacobs Levy Equity Management reported no remaining Biomea Fusion position as of Q2 2026 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 310,514 Biomea Fusion shares in Q2 2026, an estimated $475K.
  • Jacobs Levy Equity Management first reported a position in Biomea Fusion in Q4 2024 and held it in 2 quarters.
  • Jacobs Levy Equity Management's Biomea Fusion position peaked at $766K in Q4 2024.
  • 61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.